معرفی
Wenyu Fu is a research scientist at the Yale School of Medicine, Department of Orthopedics, with a strong focus on inflammation, osteoarthritis, autoimmune diseases, and bone metabolism. Working closely with Dr. Chuan-Ju Liu, Dr. Fu has contributed significantly to understanding TNF signaling, macrophage plasticity, and novel therapeutic targets such as Nav1.7 and 14-3-3ε.
The research interests of Wenyu Fu include:
- Osteoarthritis pathogenesis and therapy
- Glucocorticoid-induced osteoporosis
- TNF signaling and receptor biology
- Macrophage polarization in inflammation
- Drug repurposing for autoimmune and degenerative diseases
Analysis of recent publications reveals a consistent trajectory in identifying molecular mechanisms underlying joint and bone diseases, with a translational focus on targeting ion channels, intracellular signaling complexes, and lysosomal pathways. The work spans from basic molecular interactions to in vivo therapeutic validation.
Dr. Fu has not received publicly listed scientific awards in the provided text. However, the publication record in top journals such as Nature, Cell Research, and Journal of Clinical Investigation reflects high scientific impact.
While no formal advisees are listed, Dr. Fu likely mentors junior researchers within the Liu laboratory. Grant involvement is implied through collaborative research but not explicitly detailed. The work is conducted within a robust research environment focused on inflammation, immunology, and regenerative medicine at Yale.
Key research teams include the laboratory of Chuan-Ju Liu, focusing on immune regulation in musculoskeletal diseases, and collaborations across immunology, rheumatology, and neuroscience at Yale School of Medicine.